Submit to Brain Sciences Review for Brain Sciences

Journal Menu

Journal Browser

Neuro-oncology

A section of Brain Sciences (ISSN 2076-3425).

Section Information

The Neuro-Oncology Section of Brain Sciences publishes original research, review articles, systematic reviews, and commentaries on primary central nervous system tumors and metastases. The section aims to advance outcomes in central nervous system tumors by providing a platform for researchers, clinicians, and other healthcare professionals to share their latest findings and insights in the field of neuro-oncology.

The section covers a broad range of topics related to primary central nervous system tumors and metastases, including but not limited to:

The epidemiology, etiology, and risk factors of central nervous system tumors.
The diagnosis, imaging, and molecular profiling of central nervous system tumors, including the determination of prognostic and predictive factors for diagnoses, follow-up, and therapy.
Advanced preoperative functional neuroimaging.
Novel therapeutics, including targeted agents, immunotherapies, and gene therapies.
Surgical management, radiation therapy, and other local treatments for central nervous system tumors.
Intraoperative neurophysiological mapping and monitoring for tumor surgery.
Palliative and supportive care for patients with central nervous system tumors.
The management of metastases, including the use of stereotactic radiosurgery and systemic therapies.
Psychosocial and quality-of-life issues in patients with central nervous system tumors.
Basic research on molecular pathways involved in central nervous system tumors.

Types of articles:

The section accepts original research articles and review articles. Original research articles may include clinical trials, observational studies, or laboratory investigations related to primary central nervous system tumors or brain metastases. Review articles should provide a critical analysis of existing literature on a particular topic in neuro-oncology.

Audience: The section is intended for a broad audience of healthcare professionals and scientists involved in the care of patients with primary central nervous system tumors or brain metastases. This includes neurosurgeons, neurologists, medical oncologists, radiation oncologists, neuropathologists, and other specialists in the field of neuro-oncology. The section is also relevant to researchers in related fields, such as cancer biology, immunology, and medical imaging.

Impact: The Neuro-Oncology section aims to be a leading publication in the field of neuro-oncology, with a particular focus on advancing outcomes for patients with primary central nervous system tumors and metastases. The section seeks to foster a collaborative and interdisciplinary approach to research and clinical practice in this field. Articles published in the section will provide new insights into the biology and treatment of central nervous system tumors, with the ultimate goal of improving patient outcomes.